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Abstract
Today, a wide variety of exogenous agents (xenobiotics) collectively termed endocrine 
disrupting compounds (EDC) includes almost 1000 synthetic chemicals. The group of 
EDC is highly heterogeneous and embodies chemicals used as industrial solvents and 
their by-products (persistent organic pollutants and dioxins), plastics (bisphenol A) and 
various pesticides, herbicides and industrial pollutions. The concept of endocrine dis-
ruption refers to exogenous chemicals present in the environment, including the food 
and drugs, that a!ect human’s hormonal systems. Both epidemiological and experi-
mental evidence suggest an association between exposure to EDC and diabetes and 
related cardiometabolic disorders. These compounds are not just accumulate in the 
white adipose tissue, but also release into the blood circulation and exhibit their patho-
genic e!ects on various organs. The present review is focused on the factors in"uenc-
ing the accumulation, metabolism and release of EDC in the white adipose tissue. 
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Introduction
e exposome encompasses the to-
tality of human environmental expo-
sures from conception onwards. It was 
rst proposed by Christopher Wild in 
2005 article entitled “Complementing 
the genome with an “exposome” (1).
 Xenobiotics as a part of human ex-
posome are chemical compounds for-
eign to a given biological system. With 
respect to animals and humans, xeno-
biotics include drugs, drug metabo-
lites, and environmental chemicals 
such as synthetic pesticides, herbi-
cides, and industrial pollutants. Origi-
nally articulated in the early 1990s the 
theory of endocrine disruption refers 
to exogenous chemicals present in the 
environment and/or diet that interfere 
and disrupt physiological hormonal 
systems, inducing adverse e!ects on 
human and wildlife health (2). Today, 
the EU denition of endocrine dis-
rupting compounds (EDC) refers to: 
“an exogenous substance or mixture 
that alters function(s) of the endo-
crine system and consequently causes 
adverse health e!ects in an intact or-
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 Endocrine disrupting compounds interfere and disrupt phys-
iological hormonal balance inducing adverse e!ects on human 
health through di!erent mechanisms, such as direct interaction 
with hormone receptors, competition on binding and transport 
proteins or interference with hormone metabolism, thus block-
ing or inducing the synthesis of the hormones. A wide variety 
of chemicals act as EDC. e Endocrine Disruption Exchange 
List to date includes almost 1000 endocrine disruptors (4). e 
group of EDC is highly heterogeneous and includes synthet-
ic chemicals used as industrial solvents/lubricants and their 
by-products (persistent organic pollutants - POP), dioxins such 
as 2,3,7,8-tetrachlorodibenzo-p-dioxin - TCDD), plastics (bi-
sphenol A - BPA), pesticides (dichlorodiphenyltrichloroethane 
- DDT), plasticizers (phthalates such as diethylhexyl phthalate 
- DEHP), heavy metals (arsenic, cadmium), tributyl tin (TBT), 
triphenyltin (TPT), fungicides (vinclozolin) and pharmaceutical 
agents (diethylstilbestrol - DES). Persistent organic pollutants 
comprise a broad class of organo halides, including polychlori-
nated biphenyls (PCB), polybrominated biphenyls (PBB) and 
organochlorine pesticides. 
 Endocrine disrupting compounds are widely dispersed in the 
environment, therefore environmental human exposure occurs 
through a variety of routes and varies widely around the world. 
Food ingestion represents the major route by which people are 
exposed to EDC. For example, diet is thought to account for up 
to 90% of a person’s POP body burden (5). Taking into account 
that these pollutants are accumulated particularly in highly rank 
predators, like sh, in Sweden, consumption of fatty sh from 
the Baltic Sea is the major source of POP (6).
 White adipose tissue (WAT) is classically considered the main 
reservoir of lipids and energy (7). When stimulated by insulin, 
adipocytes store glucose as triglycerides in lipid droplets. In ad-
dition to the energy-storing, adipocytes, also other adipose tis-
sue cells, secrete - via endocrine and paracrine pathway - a large 
number of signalling proteins, collectively named adipokines 
(8, 9). Moreover, as discussed herein, WAT represents the major 
storage compartment for lipophilic contaminants, due to rapid 
penetration through the cell membranes, followed by their me-
tabolism and discharge. 
 Endocrine disrupting compounds, including POP, PCB and 
numerous other environmental chemicals, are highly attracted to 
lipids and accumulate in the WAT (10). erefore, their adipose 
storage can be considered as an internal source of chronic expo-
sure to EDC. e adipose tissues can be also the target of EDC 
that alters its functions, by increasing adipose tissue in"amma-
tion or modulating the di!erentiation of adipose precursor cells. 
For instance, TBT which acts on nuclear receptors involved in 
fat metabolism and regulation of glucose uptake, induces in an-
imals hepatic steatosis, hyperinsulinemia, hyperleptinemia and 
a reduction in hepatic adiponectin levels, in a dose-dependent 
fashion (11). Similar results, meaning the developed insulin re-
sistance syndrome, abdominal obesity and hepatosteatosis were 
obtained in adult Sprague-Dawley rats exposed for 28 days to 
crude salmon oil containing POP (12).
Factors that in!uence adipose accumulation and release 
of endocrine disrupting compounds
Physiological factors
e kinetics of accumulation by the adipose tissues depends on 
various physiological factors, but also on physicochemical prop-
erties of the EDC. e physiological factors that may in"uence 
the accumulation and also the release from the adipose tissues 
are: (i) alteration or change in the mass or composition of the 
adipose tissue or change in their perfusion rates, (ii) protein and 
lipid binding, (iii) change in the rate of EDC biotransformation, 
and (iv) change in the absorption rate. 
 It is obvious that POP storage in the adipose tissue could be 
considered a protective e!ect in respect to the general toxic ef-
fect induced by POP. Moderate or severe weight loss elicited by 
dietary changes either alone or coupled with bariatric surgery 
was associated with increased plasma concentrations of POP 
such as PCB and organochlorine pesticides (13-15), suggesting 
that the systemic presence of POP could be the result of an in-
creased lipolysis. In all studies, serum POP levels were positively 
correlated with liver toxicity markers and lipid parameters. Re-
leased POP in blood can be taken up readily by the remaining 
fat, which is essentially an innite sink, but generally the total 
POP body burden tends to decrease by 15% a#er weight loss, ex-
creted via feces, but also via lactation or placental transfer (16).
 Adipose tissues perfusion rates could in"uence the di!eren-
tial accumulation of EDC in di!erent anatomical locations. For 
instance, organochloride insecticides are accumulated in subcu-
taneous and renal adipose tissue, while POP are accumulated 
in the subcutaneous and visceral adipose tissue (17). Other re-
searchers (15) observed that the patterns of POP congeners dis-
tributions in these adipose tissues are extremely similar, there-
fore subcutaneous adipose tissue could be used to estimate total 
POP body burden. 
 Recent studies have suggested a selective distribution of PCB 
in visceral and subcutaneous adipose tissue (18, 19). e low 
chlorinated polychlorinated PCB (as PCB74, 99, 105 and 118), 
and the pesticide dichloro-diphenyl dichloroethylene were 
distributed to both visceral and subcutaneous adipose tissues, 
whereas the more highly chlorinated PCB, like PCB 153, 156, 
157, 169, 180, 206, and 209, were inversely distributed to the 
same tissues. Taking into account that visceral and subcutane-
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ous adipose tissues have di!erent contributions to the PCB se-
rum concentrations, the selective distribution may explain the 
di!erent proles of PCB in serum and adipose tissue. 
 Also the protein binding in"uences, at least partially, the 
EDC accumulation. As an example, PCB and organochlorine 
pesticides in blood are associated with the protein fraction, but 
also with lipoproteins (20). Although their binding with lipo-
proteins is considered as the major mechanism responsible for 
their accumulation, it may also be partially responsible for their 
lipotoxicity (21).
 It is well known that biotransformation has a critical impact 
on EDC accumulation but also on their toxicity. e adipose 
tissues biotransformation contributes considerably to body de-
toxication taking into account that it contains a complete set 
of enzymes such as paraoxonases, carboxylesterases and some 
isozymes of UDP-glucuronosyltransferases, several cytochrome 
P450 (CYP) isozymes such as aromatase (CYP19) being also ex-
pressed in adipocytes and their activity may play a crucial role 
in EDC-induced diabetogenic and obesogenic e!ects (reviewed 
in 22).
 Sometimes even the hepatic biotransformation can induce 
the formation of metabolites with high a$nity to adipose tis-
sues. As an example, in the case of POP, hepatic biotransforma-
tion that involves glutathione-S-transferase induces the forma-
tion of more lipophilic metabolites, via mercapturic acid path-
way. ese metabolites accumulate in lipid-rich tissues such as 
liver and WAT (23, 24). 
Physiochemical properties 
ere are several physiochemical properties that could in"uence 
the distribution and accumulation of EDC, such as pKa or mo-
lecular weight, but the most relevant characteristics are the lipid 
solubility and EDC biological-life. 
 Regarding the lipid solubility, expressed by octanol/water 
partition coe$cient (K
ow
) and its in"uence on accumulation, 
some researchers used PBPK model to predict the correlation 
between K
ow
 value and adipose-blood di!usion for highly fat 
soluble POP that have a slow and incomplete di!usion. e ad-
ipose-blood di!usion becomes rate limiting if log K
ow
 is greater 
than 5.6, and is reduced by a factor of 30 for a POP with a log K
ow 
of 7.36. At steady state, the value of log K
ow 
predicts the capacity 
of the EDC to accumulate into the adipose tissue (25).
 e biological life is directly related to EDC pathways of bio-
transformation and the rate of excretion. Based on this prop-
erty, some EDC as PCB are considered persistent, having long 
half-lives (26). It is important to underline that this parameter is 
partially in"uencing EDC total toxicity, taking into account that 
some EDC, that are rapidly degraded in the human body, may 
be present for only short periods of time but at critical periods 
of development. Of special concern are EDC such as phthal-
ates (27), PBB (28) and BPA (29), detectable in pregnant wom-
en, foetuses and newborns, taking into account that exposures 
that occur early in pregnancy can have in"uence on short-term 
health e!ects, while exposures later or during early childhood 
may induce cognitive and developmental deciencies.
Adipose tissue: the source and target of endocrine 
disrupting compounds
Lipophilic EDC are stored primarily in WAT, therefore alter-
ation or change in the mass or composition of this tissue re-
lease EDC into blood circulation, a process designated “toxo-
crine secretion” (22). As mentioned before, moderate or severe 
weight loss was associated with increased plasma levels of POP, 
like PCB and organochlorine pesticides (13-15). e increased 
plasma levels of POP induced by weight loss are also correlated 
to changes in adipose POP. Some researchers investigated POP 
concentrations in blood and adipose tissues and also assessed 
the total amount of fat mass (30). eir results indicated that the 
POP concentration in the adipose tissue increased with weight 
loss, this being correlated with the signicantly decrease of the 
total amount of fat mass. is isleading to the increased concen-
tration of POP in remained tissue. e same study revealed that 
weight loss had improved blood lipid and liver toxicity parame-
ters, but the individuals who had the highest serum POP levels 
showed a delay in improvement of these parameters (30). is 
suggests that POP presence in blood may counteract the posi-
tive e!ects of weight loss on hepatic and serum lipids.
 In the same time, POP release in the blood is correlated with 
toxic outcomes in other organs and tissues. ere is enough ev-
idence that increased serum POP levels is correlated with alter-
ations in resting metabolic rates, thermogenesis, and oxidative 
capacity of skeletal muscle (31, 32). Experimental evidence sug-
gested that fasting is accompanied by an increase in the serum 
concentration of PCB (33), but also to the redistribution of PCB 
from adipose tissue toward other lipid-rich tissues. For example, 
in rodents pretreated with hexachlorobenzene, weight loss led 
to a time-dependent increase in the brain content of hexachlo-
robenzene (34), while in mice pretreated with DDT, weight loss 
led to increased DDT level in all tissues examined (including 
brain, lung, heart, spleen, kidney, liver, adipose tissue, blood), 
except for muscle (35). e new localization of DDT in the brain 
was associated with toxic e!ects on central nervous system, once 
again suggesting that the release from adipose tissue potentially 
is correlated with toxic outcomes in other organs and tissues.
 Also the presence of lipophylic POP in breast milk is the re-
sult of the equilibrium between lipid, blood and milk, meaning 
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that it originates from the adipose tissue storage compartment, 
as well as from newly absorbed contaminants. It is important 
to underline that breastfeeding provides a signicant source of 
exposure to POP early in human life and may have signicant 
consequences on sensitive groups (infants), based on their sus-
ceptibility to hormonal e!ects (31). Disruptions induced during 
this time-frame can lead to subtle functional changes that may 
not emerge until later in life or even later, to the next generation. 
Despite the potential negative impact of POP presence in breast 
milk, breastfeeding is still recommended based on its nutritional 
and immune benets.
 e disrupting e!ects exhibited by EDC can be observed 
indi!erent tissues and organs including adipose tissue. At least 
three important e!ects are promoted at this level: disruption of 
adipose tissue function and cell di!erentiation, induction of in-
"ammation, lipotoxicity and obesogen e!ect.
Disruption of adipose tissue function
e mechanisms through which EDC could induce the disrup-
tion of adipose tissue function and cell di!erentiation are di-
verse. Some EDC are acting on other nuclear receptors involved 
in fat metabolism and regulation of glucose uptake, such as 
peroxisome proliferator-activated receptors (PPAR), especially 
on PPARγ, which are involved in the regulation of adipocyte 
di!erentiation, produc tion of adipokines or insulin responsive-
ness (36). By antagonizing PPARγ, EDC signicantly inhibit the 
release of adiponectin that has insulin-sensitizing e!ects, as it 
enhances inhibition of hepatic glucose output as well as glucose 
uptake and utilization in fat and muscle. For example, BPA at 0.1 
and 1 nM doses is a potent antagonist of PPARγ that suppresses 
adiponectin release in human adipose tissue explants (37). In 
the same time, BPA in"uences adiponectin level via another 
mechanism, that implies binding to protein disulde isomerase, 
a critical player in the retention of adiponectin in cells (38).
 Interestingly, it has been observed in vitro that the estrogen 
receptor β can act as a negative regulator of PPARγ, decreasing 
ligand-induced PPARγ and PPARγ induced adipogenesis (39), 
therefore is obvious that PPARγ function is a!ected by EDC di-
rectly interaction with the receptor, but also by EDC that modu-
late the estrogen receptor β activity. Also, TCDD inhibits adipo-
genesis through a suppression of PPARγ (40).
 Other EDC, such as phtalates (DEHP) act as potent agonists 
of PPARα or PPARγ. In rodent models, PPARα appears to me-
diate high-dose DEHP-induced body weight loss (41), but these 
e!ects cannot be extrapolated to humans, taking into account 
that the levels required to activate human PPARα are almost 
three times higher than the concentrations required to acti vate 
mouse PPARα, and the maximum-fold induction is less for hu-
man PPARα than for mouse PPARα (42).
Induction of in!ammation
Several animal studies have shown that low doses of POP, such 
as co-planar PCB77 or TCDD, increase the expression of in"am-
matory genes in adipose cells (43, 44). Another study, on the 
impact of POP on human adipose cells, showed that in pread-
ipocytes and adipocytes the in"ammatory pathway is activated 
via the AhR (45). 
 Other researchers analyzed the in"uence of POP concentra-
tions on in"ammation and insulin resistance, showing the as-
sociation between exposure and increased levels of C-reactive 
protein (46). It was demonstrated that serum levels of interleu-
kin (IL)-17, IL-1β, IL-23, and tumor necrosis factor-α (TNF-α) 
were higher in individuals who were exposed to POPs, including 
PCBs, through consumption of contaminated rice (47). 
 Taking into account that in obese individuals,circulating in-
"ammatory biomarkers such as C-reactive protein, IL-6, TNF-α, 
monocyte chemotactic protein 1, intercellular adhesion mole-
cule 1 and E-selectin have been associated with a variety of met-
abolic disorders, is obvious that increased in"ammatory media-
tors may contribute to total EDC metabolic disruption.
Lipotoxicity
ere are experimental ndings that suggested that some EDCs 
are associate with disruption of lipids homeostasis. Lipotoxicity 
and dyslipidemia induced by TCDD and low chlorinated PCB 
occur even in the absence of an obese phenotype. As an exam-
ple, PCB-77 has been shown to elevate serum very low density 
lipoprotein (LDL) in ApoE–/– mice (43), while TCDD caused an 
AhR-dependent elevated cholesterol and serum LDL in ApoE–/– 
mice (43, 48, 49). Oral exposure to DDT increased cholester-
ol and triglycerides in serum and adipose tissue and increased 
hepatic triglyceride synthesis (50). Similar ndings regarding 
increased triglyceride synthesis were observed in dieldrin-ex-
posed rats (51). 
 Lipotoxicity, assessed based on elevated cholesterol level, has 
been observed in humans a#er exposure to brominated "ame 
retardants and per"uorinated chemicals(52). Similarly, expo-
sure to per"uorinated chemicals in PPARα knockout mice in-
duced changes in gene expression and alteration of fatty acid 
metabolism (53-55). 
 National Health and Nutrition Examination Survey 
(NHANES) data demonstrated a positive association of per"u-
orooctane sulfonate (PFOS), per"uorooctanoic acid (PFOA) 
and per"uorononanoic acid (PFNA) concentrations with total 
colesterol and low density lipoprotein fraction (LDL). Linear re-
gression analysis of serum lipids and cholesterol in children with 
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high PFOA exposure, revealed that PFOA was positively associ-
ated with total cholesterol and LDL cholesterol, and that PFOS 
was positively associated with total, LDL and HDL cholesterols 
(56).
Obesogen e"ect
Several experimental studies suggested that organotins such as 
TBT and TPT have a role in obesity taking into account that 
both are activating PPARγ and consequently increase the num-
ber of di!erentiated adipocytes and disrupt normal adipogen-
esis (57).
 Phthalates, which are also known to act as PPAR activators, 
are also suspected obesogens. Published cohort studies done on 
representative sampling of the US population, using data from 
NHANES, focused on correlation between phtalate exposure 
and obesity. For example, Stahlhut et al. (58) investigated adult 
male participants in the NHANES 1999–2002 and revealed that 
urinary concentrations of three phthalate metabolites (mo-
no-n-butyl phthalate, mono-benzyl phthalate and mono-eth-
ylphtalate) were associated with increased waist circumference 
but also insulin resistance, assessed by HOMA-IR. A similar as-
sociation between urinary phthalate metabolite concentrations 
and body mass index and waist circumference was found in an-
other cross-sectional study of NHANES data (59).
 Polybrominated diethyl ethers are potential obesogens as 
well. Prenatal exposure to low doses of BDE-99 (2,2´,4,4´,5-pen-
ta-BDE) increased mouse birth weight (60), while perinatal 
exposure to BDE-47 (2,2´,4,4´-tetra-BDE) increased rat body 
weights from birth to puberty (61). 
 Another widespread obesogen is PFOA, a known PPARγ ag-
onist (62). Alterations in lipid metabolism and the obesogenic 
e!ects observed in epidemiological studies were presented be-
fore. Experimental studies in mature CD-1 mice exposed to low 
levels of PFOA (0.01-0.3mg/kg) in utero revealed an increased 
body mass, with an inverted U-shaped dose–response curve, 
indicating that PFOA acts via a non-monotonic dose response 
curve (63). It is interesting to underline that authors observed 
a positive relationship between in utero PFOA exposure levels 
and abdominal brown adipose tissue weight, but a negative re-
lationship with the mass of WAT. Consistent with experimental 
ndings, a prospective human study demonstrated that prenatal 
exposure to PFOA is associated with obesity in the daughters 
twenty years later (64). 
 
Neuronal e"ects
Nonylphenol (NP), one of the most prevalent and best-studied 
EDC, arises as a degradation product of the alkylphenol polye-
thoxylates, which are widely used as nonionic surfactants in 
commercial production, a!ects neuronal growth (65), and NP is 
also accumulated in adipose tissue (66). As with the majority of 
EDC, NP is not itself a steroid but nonetheless acts as an agonist 
at nuclear estrogen receptors and thus can be dened as an envi-
ronmental estrogen (estrogen mimetic).
Conclusion
All currently collected information indicates that adipose tis-
sue, particularly WAT, appears to play a complex role in EDC 
exposure, both in terms of adaptation and toxic e!ects. ere 
is enough evidence to suggest that adipose EDC accumulation 
and metabolism has a dual life: protective, as a reservoir at 
least in the case of acute exposure, and harmful, as an internal, 
“toxocrine” source of chronic exposure. In e!ect, adipose tis-
sue can be considered one of the major target organs of EDC, 
resulting in obesity and related cardiometabolic diseases. In-
deed, the diabesity (67) epidemic has become global health 
burden. Although the genetic and epigenetic background, in 
particular, our thri#y genes, also take part in this epidemia, 
mounting epidemiological and exprimental evidence links it 
with increases in intrauterine in"uences, viruses, microbiota, 
climate changes, and xenobiotics including EDC, all these „ex-
posure” factors being embodied in Christopher Wild’s concept 
of exposome (as indicated in the Introduction, also see 68). 
Hence, biomonitoring adipose EDC, also milk, could be an 
important marker of such an exposure. e standardization 
of such procedures at clincolaboratory level is required. Alto-
gether, further studies are needed to enrich our knowledge in 
human exposure to EDC and to investigate its consequences as 
well as prediction and prevention.
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